Comments on Condition of the Public Health Industrial Base and Recommendations

Share page:
Docket Number:
BIS-2020-0034

Supply chain resilience is essential to ensure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises. While there is a strong U.S. manufacturing capacity for consumer healthcare products in finished dosage form, supply chain resilience relies on a diverse, global supply chain to reduce the risk of shortages or disruptions that may occur in a particular geographical area. Such disruptions not only include pandemics or geopolitical issues, but issues within the U.S., such as a natural disaster. Having ingredient suppliers in different parts of the world allows manufacturers an alternate source for procurement when an interruption occurs to reduce the impact of such disruptions.

Related Posts

CHPA Welcomes New Board Members at June Meeting